发明名称 |
METHOD FOR PREDICTION OF ANTI-OESTROGEN TAMOXIFEN THERAPY EFFECTIVENESS IN PATIENTS WITH LUMINAL BREAST CANCER |
摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, particularly oncology and aims at predicting the anti-oestrogen tamoxifen therapy effectiveness. An immune histochemical analysis of a tumour tissue is performed in the patients suffering luminal breast cancer, and a tumour tissue distribution pattern of oestrogen receptors alpha expression is described. Rs2228480 G/A polymorphism is stated in exon 8 of oestrogen receptors alpha (ER?) gene by real-time polymerase chain reaction. The state of regional lymph nodes is assessed. The tumour grade and the anti-oestrogen tamoxifen therapy effectiveness are calculated by formula. If P>0.5, the high anti-oestrogen tamoxifen therapy effectiveness is predicted. P<0.5 shows the low therapy effectiveness and a high probability of progression are predicted.EFFECT: invention is very likely to predict of the therapy effectiveness and thereby applying an individual approach to choose a type of hormonal treatment in the patients suffering luminal breast cancer.2 tbl, 2 ex |
申请公布号 |
RU2558857(C1) |
申请公布日期 |
2015.08.10 |
申请号 |
RU20140103950 |
申请日期 |
2014.02.04 |
申请人 |
FEDERAL'NOE GOSUDARSTVENNOE BJUDZHETNOE NAUCHNOE UCHREZHDENIE "TOMSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ INSTITUT ONKOLOGII" (TOMSKIJ NII ONKOLOGII) |
发明人 |
SLONIMSKAJA ELENA MIKHAJLOVNA;BABYSHKINA NATAL'JA NIKOLAEVNA;PATALJAK STANISLAV VIKTOROVICH;ZAV'JALOVA MARINA VIKTOROVNA;VTORUSHIN SERGEJ VLADIMIROVICH |
分类号 |
G01N33/68;G01N33/50 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|